ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019)
ENDRA Life Sciences (NDRA) reported Asset Writedowns and Impairment of $249256.0 for Q4 2019, down 13.31% quarter-over-quarter from $287541.0 in Q3 2018.
ENDRA Life Sciences (NDRA) Asset Writedowns and Impairment (2018 - 2019) Analysis & Trends
ENDRA Life Sciences (NDRA) has 2 years of Asset Writedowns and Impairment data on file, last reported at $249256.0 in Q4 2019.
- Asset Writedowns and Impairment for Q4 2019 came in at $249256.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $536797.0 (up 86.69% YoY), and the FY2019 annual result was $249256.0, down 13.31% from the prior year.
- Asset Writedowns and Impairment slipped to $249256.0 in Q4 2019 per NDRA's latest filing, from $287541.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $287541.0 in Q3 2018 and troughed at $249256.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 249,256.00 |
| Dec 31, 2019 | 249,256.00 |
| Sep 30, 2018 | 287,541.00 |
| Sep 30, 2018 | 287,541.00 |